DrugBase
RECENT UPDATES
HOME
DRUGS
NEWS
ARTICLES
COMMUNITY
INFO
Latest News
MISCELLANEOUS
0
Share This!
Share
Share
Share
Share
More 0
Respected Sites
Latest Drugs
VFEND
Tonus
Phenytin
Tremodect
Ofusidic
Latest Articles
Podophyllin Resin in Management
of Genital Warts
Digestin vs. Neo-Digestin
Diclofenac Potassium vs.
Diclofenac Sodium
Latest Community
Hydrocortisone 100 mg Ampoules
Egypt MOH Announces Latest
Hepatitis C Treatment Next June
at Fraction of International Price
Abimol and Ventolin Syrups:
Recall of Faulty Batches
Tradename
Invanz
Generic Name
Need Help?
Ertapenem
Category
Antimicrobials
Form
Vial
Composition
Ertapenem sodium.........1 g
Description
Properties/Actions
Indications
Invanz is indicated for the treatment of adult patients and pediatric patients (3 months of age and
older) with the following moderate to severe infections caused by susceptible isolates of the designated
microorganisms:
1. Complicated intra-abdominal infections: Invanz is indicated for the treatment of complicated intraabdominal infections due to Escherichia coli, Clostridium clostridioforme, Eubacterium lentum,
Peptostreptococcus species, Bacteroides fragilis, Bacteroides distasonis, Bacteroides ovatus, Bacteroides
thetaiotaomicron, or Bacteroides uniformis.
2. Complicated skin and skin structure infections, including diabetic food infections without
osteomyelitis: Invanz is indicated for the treatment of complicated skin and skin structure infections,
including diabetic foot infections without osteomyelitis due to Staphylococcus aureus (methicillin
susceptible isolates only), Streptococcus agalactiae, Streptococcus pyogenes, Escherichia coli,
Klebsiella pneumoniae, Proteus mirabilis, Bacteroides fragilis, Peptostreptococcus species,
Porphyromonas asaccharolytica, or Prevotella bivia. Invanz has not been studied in diabetic foot infections
with concomitant osteomyelitis
3. Community acquired penumonia: Invanz is indicated for the treatment of community acquired
pneumonia due to Streptococcus pneumoniae (penicillin susceptible isolates only) including cases with
concurrent bacteremia, Haemophilus influenzae (beta-lactamase negative isolates only), or Moraxella
catarrhalis.
4. Complicated urinary tract infections including pyelonephritis: Invanz is indicated for the treatment
of complicated urinary tract infections including pyelonephritis due to Escherichia coli, including cases with
concurrent bacteremia, or Klebsiella pneumoniae.
5. Acute pelvic infections including post-partum endomyometritis, septic aborion and postsurgical gynecological infections: Invanz is indicated for the treatment of acute pelvic infections
including postpartum endomyometritis, septic abortion and post surgical gynecological infections due to
Streptococcus agalactiae, Escherichia coli, Bacteroides fragilis, Porphyromonas asaccharolytica,
Peptostreptococcus species, or Prevotella bivia.
6. Prophylaxis of surgical site infection following elective colorectal surgery: Invanz is indicated for
the prevention of surgical site infection following elective colorectal surgery.
Contraindications
Drug Interactions
Side Effects/Adverse Effects
Pregnancy & Lactation
Dosage & Administration
Overdosage
Warnings
Notes
Storage
Packaging
Manufacturer
Date Added/Updated
3rd June 2012 11:46pm
http://drugbase.org/drugs/drug_details.php?drugid=1969#.U62zrPmSwms
1/2
6/27/2014
DrugBase 2009-2014
OrderofJaCkAl Network Partner
http://drugbase.org/drugs/drug_details.php?drugid=1969#.U62zrPmSwms
2/2